Cochlear (ASX:COH) announces the launch of the Nucleus® ProfileTM Plus Series implant

Cochlear today announces the launch of the Nucleus® Profile™ Plus Series cochlear implant, designed for routine 1.5 and 3 Tesla magnetic resonance imaging scans without the need to remove the internal magnet.

Commercial availability commences in Germany with other European countries to follow over the coming months. The Nucleus Profile Plus series implant is expected to be launched across other developed markets over the coming months, subject to the timing of regulatory approvals.

Categories: Australian Stocks

Tags: , , , ,

%d bloggers like this: